New twice-yearly HIV injection set to boost medication adherence in Zimbabwe
Health authorities have said the long-acting antiretroviral drug, Lenacapavir (LEN) is expected dramatically improve patient compliance by removing the need for daily pills.
By Nizbert Moyo
Jun. 24, 2026
The US$4.4 billion handshake: China’s new vision for a modernising Zimbabwe
Local News
By ZHOU DING
6h ago
Kadoma businessman reports lawyer to Law Society of Zimbabwe over alleged unethical conduct
Local News
7h ago




